Hayashi, Yudai, et al. “Combined Impact of Prior Polatuzumab Vedotin Plus Bendamustine and Rituximab Therapy and Myeloablative Conditioning on Early Post-Transplant BK Virus-Associated Hemorrhagic Cystitis”. Journal of Hematology, vol. 14, no. 2, Apr. 2025, pp. 66-73, https://doi.org/10.14740/jh2010.